Skip to main content
Equibles

Jacqualyn A. Fouse, Ph.D.

Board Member

Agios Pharmaceuticals, Inc. (AGIO)

Equibles does not estimate personal net worth.

Get an email with a short summary when Agios Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get AGIO alerts

About Jacqualyn A. Fouse, Ph.D.

Jacqualyn A. Fouse, Ph.D. is recorded as Board Member at Agios Pharmaceuticals, Inc. (AGIO) since June 18, 2025. Agios Pharmaceuticals, Inc. reported in an 8-K filed June 18, 2025 that Jacqualyn A. Fouse, Ph.D. was appointed Class III director, effective June 18, 2025. Agios Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Agios Pharmaceuticals, Inc. includes Brian Goff (CEO and Board Member), Jacqualyn Fouse (CEO and Board Member), David P. Schenkein (Chairman) and 7 others.

“The Company's stockholders elected Jacqualyn A. Fouse, Ph.D. and David Scadden, M.D. as Class III directors, each to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified.”
Agios Pharmaceuticals, Inc. Form 8-K, filed June 18, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Agios Pharmaceuticals, Inc.

Recent activity